Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Univ. Spinoff Qualifies for NIH Clinical Program

Kate Rittenhouse-Olson and John Fisk

An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials. . . . → Read More: Univ. Spinoff Qualifies for NIH Clinical Program

Trial Underway Testing Universal Flu Vaccine

Influenza virus

A clinical trial is recruiting participants to test a vaccine to protect against a variety of influenza strains, instead of today’s vaccines designed to prevent infections from specific strains expected in a given year. . . . → Read More: Trial Underway Testing Universal Flu Vaccine

Global Health R&D Cuts Threaten U.S. Economy, Jobs

Children receiving vaccine

An analysis of the impact of proposed cuts in funds for research and development on technologies to address global health needs shows the U.S. economy benefits directly from this spending, including support of many jobs in nearly all states. . . . → Read More: Global Health R&D Cuts Threaten U.S. Economy, Jobs

Cough Suppressant Produced from Engineered Yeast Cells

A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells

Cancer Drug Seen to Reverse Autism Spectrum Symptoms

Small doses of a drug for blood-related cancers are shown in lab mice to reverse social symptoms often found in children with autism spectrum disorder, a condition characterized by limited social activity. . . . → Read More: Cancer Drug Seen to Reverse Autism Spectrum Symptoms

Trials Test Antibodies to Prevent Hospital Infections

Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics. . . . → Read More: Trials Test Antibodies to Prevent Hospital Infections

NIH Exec: Research Offers Opioid Crisis Solutions

The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths. . . . → Read More: NIH Exec: Research Offers Opioid Crisis Solutions

Cardiac Augmented-Reality Hologram System in Development

A start-up company spun-off from Washington University in St. Louis was awarded a grant to advance an augmented reality system that displays an interactive hologram of a patient’s heart, to simplify cardiac procedures. . . . → Read More: Cardiac Augmented-Reality Hologram System in Development

NIH Funding Immune-Friendly Synthetic Vascular Grafts

A bioengineering lab is receiving a National Institutes of Health grant to advance development of more tolerable synthetic veins and arteries implanted in heart bypass patients. . . . → Read More: NIH Funding Immune-Friendly Synthetic Vascular Grafts

Technique Developed for High-Speed Antibody Screening

A process is being developed to quickly discover antibodies in a person’s immune system that can also lead to new vaccines and drugs against viruses. . . . → Read More: Technique Developed for High-Speed Antibody Screening